Home/Filings/4/0001209191-20-009645
4//SEC Filing

Do Hung 4

Accession 0001209191-20-009645

CIK 0001178879other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 4:19 PM ET

Size

16.9 KB

Accession

0001209191-20-009645

Insider Transaction Report

Form 4
Period: 2020-02-12
Do Hung
Sr Vice President Discovery
Transactions
  • Exercise/Conversion

    Common Stock

    2020-02-12$8.61/sh+6,300$54,243527,455 total
  • Exercise/Conversion

    Common Stock

    2020-02-12$6.10/sh+29,148$177,803556,603 total
  • Exercise/Conversion

    Common Stock

    2020-02-12$5.13/sh+17,652$90,555574,255 total
  • Sale

    Common Stock

    2020-02-12$11.01/sh63,356$697,340510,899 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2020-02-126,30043,700 total
    Exercise: $8.61Exp: 2025-01-02Common Stock (6,300 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2020-02-1229,1486,270 total
    Exercise: $6.10Exp: 2026-06-15Common Stock (29,148 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2020-02-1217,65219,133 total
    Exercise: $5.13Exp: 2027-01-03Common Stock (17,652 underlying)
Footnotes (5)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • [F2]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.00 to $11.03 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]All of the options were fully vested and exercisable as of February 12, 2020.
  • [F4]As of February 12, 2020, 45,812 options were fully vested and exercisable and 4,188 remained unvested from this grant.
  • [F5]As of February 12, 2020, 20,594 options were fully vested and exercisable and 16,191 remained unvested from this grant.

Issuer

AMICUS THERAPEUTICS, INC.

CIK 0001178879

Entity typeother

Related Parties

1
  • filerCIK 0001593353

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:19 PM ET
Size
16.9 KB